Data is not available at this time.
Shofu Inc. operates as a specialized manufacturer and global supplier of dental materials and equipment, serving dental professionals worldwide. The company’s diversified product portfolio includes artificial teeth, dental porcelains, restorative materials, orthodontic devices, and infection control products, catering to both clinical and laboratory dental needs. With a century-long legacy since its founding in 1922, Shofu has established itself as a trusted brand in the dental industry, leveraging its expertise in material science and precision manufacturing. The company’s revenue model is driven by recurring sales of consumable dental products and capital equipment, benefiting from steady demand in dental care. Positioned in the competitive medical instruments and supplies sector, Shofu differentiates itself through product reliability, innovation, and a strong distribution network. Its market presence spans Japan and international markets, where it competes with global dental giants while maintaining a niche focus on high-quality, specialized solutions.
Shofu reported revenue of JPY 35.1 billion for FY 2024, with net income of JPY 3.7 billion, reflecting a net margin of approximately 10.4%. The company’s operating cash flow stood at JPY 3.1 billion, while capital expenditures were JPY 1.7 billion, indicating disciplined investment in maintaining production capabilities. These metrics suggest stable profitability and efficient capital deployment in its niche market.
The company’s diluted EPS of JPY 102.63 underscores its earnings power, supported by a capital-light business model focused on high-margin dental consumables. With minimal total debt of JPY 281 million and robust cash reserves of JPY 9.7 billion, Shofu demonstrates strong capital efficiency and financial flexibility to fund growth initiatives or shareholder returns.
Shofu maintains a conservative balance sheet, with cash and equivalents nearly 35 times its total debt, highlighting negligible leverage. The company’s net cash position and low beta of 0.27 reflect financial stability and resilience to market volatility, aligning with its defensive sector positioning.
While specific growth rates are undisclosed, Shofu’s focus on dental consumables suggests steady demand tied to global dental care trends. The company’s dividend per share of JPY 44 indicates a commitment to returning capital, supported by its strong cash generation and low payout ratio.
At a market cap of JPY 76.7 billion, Shofu trades at a P/E of approximately 21x based on FY 2024 earnings. This valuation reflects investor confidence in its niche market position and consistent profitability, though growth expectations appear modest given its mature industry.
Shofu’s long-standing reputation, product diversification, and financial prudence position it well for sustained performance. The company’s outlook is stable, supported by recurring demand for dental products, though innovation and international expansion could provide incremental growth opportunities in a competitive landscape.
Company filings, market data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |